ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RMD Resmed Inc

32.79
-0.11 (-0.33%)
01 May 2024 - Closed
Delayed by 20 minutes
Share Name Share Symbol Market Type
Resmed Inc ASX:RMD Australian Stock Exchange Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.11 -0.33% 32.79 32.60 32.77 33.00 32.74 32.75 2,874,926 09:50:00

ResMed Announces Participation in the William Blair 40th Annual Growth Stock Conference

03/06/2020 2:00pm

Business Wire


Resmed (ASX:RMD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Resmed Charts.

ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, 2020, beginning at approximately 12:00 p.m. (Central Daylight Time) via video webcast.

More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible through July 10, 2020, following the conference.

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com

For media Jayme Rubenstein +1 858.836.6798 news@resmed.com

 

1 Year Resmed Chart

1 Year Resmed Chart

1 Month Resmed Chart

1 Month Resmed Chart

Your Recent History

Delayed Upgrade Clock